TMEM220 and hepatocellular carcinoma: The data in Table 1 show that low levels of TMEM220-AS1 were associated with malignant clinical parameters of HCC, including advanced TNM stage (P=0.014), venous infiltration (P=0.007), and tumor size > 5 cm (P=0.017).